What Bioscience does

Bioscience (天津博奥赛斯生物科技股份有限公司 / Tianjin Bioscience Diagnostic Technology Co., Ltd.) is a Tianjin-based in vitro diagnostics (IVD) company founded in 2010 that develops and manufactures a multi-platform diagnostic instrument portfolio under the Axceed brand, spanning chemiluminescence immunoassay (CLIA; series 210, 260, 360, 560, 400T, 200T, PETECK 96-I), point-of-care testing (POCT; Axceed P200 and Axceed 120), clinical mass spectrometry (LC-MS/MS Axceed LC-MS F and Axceed LC-MS T), and inductively coupled plasma mass spectrometry (Axceed ICP-MS X). The company also markets a reagent menu covering tumor markers, cardiac markers, thyroid function, infectious diseases, hormones, and other analytes, and has introduced a CLIS beta full laboratory automation solution aimed at total-workflow integration for hospital laboratories.

The company monetizes through a combination of instrument placement and recurring reagent consumption across five customer segments: hospitals, independent clinical laboratories, screening centers, CDC and customs agencies, and home-testing users. Distribution is executed via direct sales through regional offices covering all major Chinese provinces, supplemented by international distribution reaching 10+ countries. R&D is anchored by an Academician workstation led by Chen Hongyuan (陈洪渊), a Postdoctoral Research Workstation established in 2024, and a portfolio of 100+ patents and 400+ NMPA product registrations. The firm has been designated a MIIT "Specialized, Refined, Novel and Small Giant" enterprise (2022), received the National May 1st Labor Award (2022), achieved CNAS certification (2023), and had its Axceed LC-MS T platform included on the MIIT First Set Major Technical Equipment Insurance Compensation List in 2025 — a combination of credentials that positions it competitively in China's domestic IVD procurement environment while it pursues higher-value clinical mass spectrometry and total-lab-automation segments.

Name

Bioscience

Legal name

天津博奥赛斯生物科技股份有限公司

Website

https://bioscience-tj.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioscience is a Tianjin-based IVD manufacturer (founded 2010) selling Axceed-brand chemiluminescence, POCT, LC-MS/MS, and ICP-MS instruments plus reagent menus to hospitals, labs, screening centers, and public health agencies across China and 10+ international markets.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD) and Clinical Diagnostic Instruments

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• In vitro diagnostics
• Chemiluminescence immunoassay
• Clinical mass spectrometry
• POCT rapid diagnostics
• Automated laboratory systems

Headquarters

HQ city

Tianjin

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. IVD Instruments and Reagents Sales: Sale of chemiluminescence immunoassay instruments (Axceed series), POCT analyzers (Axceed P200, Axceed 120), automated流水线 (CLIS beta), LC-MS systems (Axceed LC-MS F/T, Axceed ICP-MS X), and corresponding reagent kits across multiple diagnostic categories including tumor markers, cardiac markers, thyroid function, infectious diseases, diabetes, hypertension, and reproductive hormones. Revenue is generated through one-time instrument sales combined with recurring reagent/consumable revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Bioscience designs, manufactures, and sells in vitro diagnostic (IVD) instruments and reagent kits for clinical laboratories. Its portfolio spans chemiluminescence immunoassay analyzers (Axceed series), POCT/colloidal gold analyzers, fully automated laboratory assembly lines (CLIS beta), LC-MS/MS systems (Axceed LC-MS F/T), ICP-MS trace element analyzers, and comprehensive reagent panels covering tumor markers, cardiac markers, thyroid function, infectious diseases, reproductive hormones, diabetes, hypertension, autoantibodies, and other biomarkers.

Product overview

Bioscience Diagnostic Technology Co., Ltd is a high-tech enterprise integrating R&D, production and sales of in vitro diagnostic products. The company operates a multi-platform product portfolio comprising: (1) Chemiluminescence immunoassay instruments (Axceed series: 210, 260, 360, 560, 400T, 200T, PETECK 96-I) using magnetic particle and conventional chemiluminescence technologies; (2) Full laboratory automated assembly line (CLIS beta) for connecting multiple analyzers; (3) POCT instruments (Axceed P200, Axceed 120) for point-of-care testing; (4) Clinical mass spectrometry systems (Axceed LC-MS F, Axceed LC-MS T, Axceed ICP-MS X) for liquid chromatography-tandem mass spectrometry and trace element analysis; (5) Comprehensive reagent panels covering tumor markers, cardiac markers, thyroid function, infectious diseases, sexual hormones, diabetes, hypertension, bone metabolism, anemia, coagulation, liver fibrosis, lung function, and autoantibodies; and (6) Laboratory auxiliary equipment including automatic reagent preparation instruments and microplate dehydration instruments. The company also offers single-dose chemiluminescence reagents compatible with Axceed 210 and Axceed 560 systems. Products are manufactured in both Tianjin and Chongqing facilities with over 400 medical device registration certificates.

Differentiator

Problem solved

Functional benefit

Brands

• Axceed: Chemiluminescence immunoassay instrument brand including Axceed 210, Axceed 260, Axceed 360, Axceed 400T, Axceed 200T, Axceed 560, Axceed 120, Axceed P200
• PETECK
• CLIS beta
• Axceed LC-MS
• Axceed ICP-MS X

Products and services

• Axceed 210 (6-channel) Single-dose chemiluminescence immunoassay analyzer with 6 channels, 15.6-inch full-color touchscreen, disposable Tip head sampling, 24-hour standby, and built-in thermal printer. Designed for small to medium clinical laboratories and point-of-use settings.
• Axceed 210 (20-channel) Single-dose chemiluminescence immunoassay analyzer with 20 channels (5 reaction chambers x 4 tests) supporting random access and batch testing. Designed for clinical laboratories requiring higher throughput per single-dose instrument.
• Axceed 260 Fully automated magnetic particle chemiluminescence immunoassay analyzer with 60 sample positions (10 emergency), 18 refrigerated reagent positions, and 90 constant-temperature reaction positions. Supports direct loading of original collection tubes for hospital clinical laboratories.
• Axceed 360 Fully automated magnetic particle chemiluminescence immunoassay system with 140 sample positions (15 emergency), track-style sampling, 32 refrigerated reagent positions, and 134 temperature-controlled incubation positions. Designed for mid- to high-volume hospital laboratories.
• Axceed 560 Ultra-high-speed fully automated magnetic particle chemiluminescence immunoassay system with single-module throughput of 1200 tests/hour and four-unit linkage reaching 4800 tests/hour; loads up to 660 samples at once. Designed for high-throughput centralized laboratories.
• Axceed 400T Chemiluminescence immunoassay instrument with 96 sample positions supporting original collection tubes and 48 reagent positions; features built-in plate washer and detector for ELISA plate-based testing.
• Axceed 200T Chemiluminescence immunoassay instrument with 32 reagent positions, supporting multi-project simultaneous online testing with independent pipetting needles and liquid surface detection.
• PETECK 96-I Chemiluminescence immunoassay instrument for 96-well plate testing.
• CLIS beta Open shared laboratory automation assembly line connecting up to 20 instruments, featuring RFID sample identification, real-time sample positioning tracking, and flexible layout configurations (I-type, U-type, Z-type, T-type designs) for high-throughput clinical laboratories.
• Axceed P200 Point-of-care testing instrument with 7-inch LCD touchscreen, built-in thermal printer, RFID batch standard curve import, QR code scanning, Ethernet and Wi-Fi connectivity, and LIS connection.
• Axceed 120 Fully automated colloidal gold immunochromatographic analyzer with testing speed of 120 tests/hour, automated sample tube inversion and squeezing for sampling, maximum 250 test cards loading capacity.
• Axceed LC-MS F Liquid chromatography-tandem mass spectrometry (LC-MS/MS) system for clinical diagnostics enabling precise separation and quantitative analysis of trace components in samples.
• Axceed LC-MS T Ultra-high performance liquid chromatography-tandem mass spectrometry system combining high separation capability with high sensitivity and selectivity for precise clinical diagnostics; selected for the national First Set equipment list.
• Axceed ICP-MS X Inductively coupled plasma mass spectrometry (ICP-MS) system for trace element analysis in clinical diagnostics, supporting multi-element detection including heavy metals.
• Single-Dose Chemiluminescence Reagent Series Single-dose chemiluminescence reagent kits covering infectious disease, thyroid function, tumor markers, cardiac markers, diabetes, hypertension, bone metabolism, sexual hormones, coagulation, and other series, for use with Axceed 210 and Axceed 560 instruments.
• Chemiluminescence Reagent Series (Tumor, Cardiac, Thyroid, Infectious, Hormones, Diabetes, Hypertension, Liver Fibrosis, Coagulation, Anemia, Bone Metabolism, Autoimmune) Magnetic particle and conventional chemiluminescence reagent kits covering tumor markers (36+ items), cardiac markers, thyroid function (17+ items), infectious diseases, sexual hormones, and other diagnostic panels including liver fibrosis, lung function, coagulation, anemia, bone metabolism, diabetes, and hypertension series.
• COVID-19 Antigen/Antibody Detection Reagents COVID-19 antigen and antibody detection reagents using magnetic particle chemiluminescence, colloidal gold, and conventional chemiluminescence methods for infectious disease screening and outbreak monitoring.
• LC-MS Detection Reagent Kits LC-MS reagent kits covering vitamins (25-OH VD, water-soluble and fat-soluble vitamins), bile acids, steroid hormones, homocysteine, and therapeutic drug monitoring (anti-tumor, anti-depressant, anti-epileptic drugs, immunosuppressants).
• ICP-MS Detection Reagent Kits ICP-MS reagent kits for trace element analysis including 7-element, 9-element, 10-element, 12-element, 13-element, and 15-element panels covering calcium, magnesium, iron, copper, zinc, lead, mercury, and other trace elements.
• Autoantibody Detection Reagents Autoantibody detection reagent kits for use with the Axceed 260 analyzer, including ANA series (PCNA, Ro-52, Jo-1, Scl-70, CENP-B, PM-Scl, AMA-M2), autoimmune liver disease series (Sp100, LC-1, SLA/LP, LKM-1), ANCA series (PR3, GBM, MPO), rheumatoid arthritis series (RF-IgA/G/M, CCP), and antiphospholipid syndrome series (β2-GP1, aCL).
• Automatic Reagent Preparation Instrument Automatic reagent preparation instrument with processing speed ≥60L/H, supporting continuous reagent preparation and connection to single or multiple testing instruments and laboratory assembly lines.
• Microplate Dehydration Instrument Microplate dehydration instrument with standardized plate shaking function, UV disinfection, fastest dehydration time of 10 seconds, supporting 2-4 plates per run.

Quantifiable outcome

• COVID-19 IgM/IgG antibody test: First globally to receive NMPA approval (Feb 29, 2020) for high-sensitivity, high-throughput SARS-CoV-2 serology testing system.
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Da An Gene (Sun Yat-sen University Da An Gene): Da An Gene is a Chinese molecular and immunoassay diagnostics company offering CLIA and PCR-based systems. Its clinical diagnostic menu and hospital sales motion closely parallel Bioscience's go-to-market approach.
• DiaSorin: DiaSorin is a global specialty IVD company focused on chemiluminescence immunoassays and clinical mass spectrometry. Its LIAISON platform and specialty vitamin/steroid assays via mass spec closely mirror Bioscience's Axceed LC-MS and reagent strategy.
• Beijing Strong Biotechnologies: Beijing Strong is a Chinese IVD manufacturer specializing in chemiluminescence immunoassay analyzers and reagents with comparable test menus for tumor markers, hormones, and infectious disease, serving overlapping hospital customers in China.
• Autobio Diagnostics: Autobio is a major Chinese IVD manufacturer offering immunoassay analyzers, microbiology, and clinical chemistry systems. Its AutoLumo series competes directly with Bioscience's Axceed line for Chinese hospital and independent lab customers.
• Maccura Biotechnology: Maccura is a Chinese IVD player with chemiluminescence immunoassay, clinical chemistry, and POCT offerings targeting similar hospital and clinical lab customers. It competes with Bioscience across both instruments and reagent panels.
• Shenzhen New Industries Biomedical Engineering (Snibe): Snibe is a leading Chinese chemiluminescence immunoassay (CLIA) specialist with a directly comparable product portfolio of MAGLUMI series analyzers and broad reagent menu. It is the closest head-to-head competitor to Bioscience's Axceed CLIA platform in both hospital labs and high-throughput reference labs.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is the global IVD leader with the cobas immunoassay and clinical chemistry platform. It represents the premium-tier incumbent that Bioscience's Axceed CLIA systems compete against in tier-1 Chinese hospitals.
• Mindray Bio-Medical Electronics: Mindray is a dominant Chinese medical device and IVD incumbent offering CLIA analyzers (CL-series), hematology, and patient monitoring. It competes with Bioscience across nearly every IVD segment but operates at much greater scale and with broader global distribution.
• Abbott Diagnostics: Abbott Diagnostics offers the ARCHITECT immunoassay platform and the Alinity series, with a broad menu spanning infectious disease, cardiac, and reproductive testing. It competes with Bioscience in higher-end Chinese hospital and reference lab settings.

Emerging players

• Wuhan Easy Diagnosis Biomedicine: Wuhan Easy Diagnosis is a smaller Chinese IVD player focused on chemiluminescence and POCT reagents. It targets similar mid-tier hospital customers as Bioscience but with a narrower product line, representing an emerging competitive threat in specific test categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/bioscience-tianjin-diagnostic-technology-co-ltd

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioscience